GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                            
                                
                                                                Synonyms: REGN-910 | REGN910 | SAR307746
                                 
                                                         
                            Compound class: 
                                                            Antibody
                                 
                                
                                    
                                        Comment: Nesvacumab is a fully human monoclonal antibody that targets angiopoietin-2 (ANGPT2, aka ANG2), being investigated as an antiangiogenic anti-tumour agent. 
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                    
                                    
                                    Peptide sequences for this antibody are available from its IMGT/mAb-DB record.  | 
                                    
Classification ![]()  | 
                                                    |
| Compound class | Antibody | 
International Nonproprietary Names ![]()  | 
                                                        |
| INN number | INN | 
| 9688 | nesvacumab | 
Synonyms ![]()  | 
                                                        
| REGN-910 | REGN910 | SAR307746 | 
Database Links ![]()  | 
                                                        |
| Specialist databases | |
| IMGT/mAb-DB | 452 | 
| Other databases | |
| GtoPdb PubChem SID | 252166667 | 
| Search PubMed clinical trials | nesvacumab | 
| Search PubMed titles | nesvacumab | 
| Search PubMed titles/abstracts | nesvacumab | 
| Wikipedia | Nesvacumab |